Do blood pressure lowering medications improve mortality and clinical outcomes in patients with type 2 diabetes?
Blood pressure lowering improves mortality and clinical outcomes in patients with type 2 diabetes, particularly when baseline blood pressure is 140 mm Hg or higher.
Among patients with type 2 diabetes, BP lowering was associated with improved mortality and other clinical outcomes with lower RRs observed among those with baseline BP of 140 mm Hg and greater. These findings support the use of medications for BP lowering in these patients.
Emdin et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: